Royalty Pharma plc

Ownership Transactions Reported by 20 Insiders

Symbol
RPRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
110 East 59 Th Street, New York, NY

Insiders trading volume in the past year

Royalty Pharma plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gg 1978 Sicaf Sif S.A. 10%+ Owner $608M Sep 14, 2022
GG 1978 SICAF SIF S.A. - GG Strategic 10%+ Owner $590M Sep 20, 2022
Mario Germano Giuliani Director, 10%+ Owner $96M Jun 23, 2023
Avara Management Ltd 10%+ Owner $68.5M -$28.7M -29.5% Dec 29, 2023
William E. Ford Director $56.4M Jun 30, 2021
George W. Lloyd EVP, Investments & CLO $29.7M Aug 12, 2024
James F. Reddoch EVP & Chief Scientific Officer $23.3M Sep 28, 2022
Rory B. Riggs Director $11.6M -$13.2M -53.3% Feb 20, 2024
Christopher Hite EVP & Vice Chairman $11.2M May 13, 2024
Pablo G. Legorreta CEO, Chairman of the Board, Director, 10%+ Owner $9.81M Jun 28, 2023
Henry A. Fernandez Director $2.97M Jun 28, 2024
Gregory Norden Director $2.23M Jun 7, 2024
Errol B. Desouza Director $2.23M Jun 7, 2024
Bonnie L. Bassler Director $1.57M Jun 28, 2024
Ted W. Love Director $1.4M Jun 7, 2024
Catherine M. Engelbert Director $1.32M Jun 7, 2024
David C. Hodgson Director $777K Jun 7, 2024
MGG Strategic SICAF SIF S.A. 10%+ Owner Apr 1, 2022
Marshall Urist EVP, Research & Investments Aug 12, 2024
Terrance P. Coyne Evp & Cfo Aug 12, 2024

Recent Insider Transactions by Companies or Individuals for Royalty Pharma plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.